# Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients

> **NCT02108444** · — · COMPLETED · sponsor: **Peking University** · enrollment: 107 (actual)

## Conditions studied

- Hepatitis
- Hepatitis B
- Lymphoma
- Hematologic Diseases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02108444
- **Lead sponsor:** Peking University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2013-12
- **Final completion:** 2014-03
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2014-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02108444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02108444, "Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02108444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*